BridgeBio Pharma Inc Roundtable Discussion Transcript
Good day, and thank you for standing by. Welcome to BridgeBio's Achondroplasia Educational Roundtable Event. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Dr. Neil Kumar, BridgeBio Founder and CEO. Please go ahead.
Thanks, operator. Appreciate the time, and I appreciate everyone taking the time today. We're privileged to spend the coming almost hour with Dr. Irving, who I'll introduce in a moment. The objectives of today's call in response to a bunch of questions that we've been getting from many of you over the past few months are simple and are really the following 4: number one, to better understand the unmet need associated with achondroplasia and related skeletal dysplasias; number two, to understand the path of mechanism of this disease as many of you know, this is a well-described disease; number three, within that context of understanding both the molecular path
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |